REGISTRATION IS CLOSED
1 hour of reading prior to the event date is required to receive your full 8 clinical hours for your DEA MATE Act requirement.
The list of suggested readings is below. Read for one hour. You do not need to read all of them. Pick one.
HANDOUT #1 January 12, 2024
PDF, 30.49 MB
HANDOUT #2 January 12,2024
PDF, 18.73 MB
HANDOUT #3 January12,2024
PDF, 1.38 MB
Navigating Addiction and Treatment Guide
PDF, 20.36 MB
Drugs of AbuseDEA2022
PDF, 12.87 MB
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
PDF, 1.28 MB
PDF, 1.49 MB
PDF, 1.10 MB
PDF, 283.00 KB
PDF, 842.65 KB
PDF, 259.18 KB
PDF, 209.31 KB
PDF, 103.07 KB
In December 2022, Congress passed a federal law that requires controlled substance prescribers to complete 8 hours of one-time training on safe controlled substance prescribing as a condition of receiving or renewing a DEA registration. In order to provide guidance to the states and its members, the American Dental Association (ADA) requested clarification on a number of questions of uncertainty with the legislation. That guidance can be found at FAQs on the new controlled substance education requirement for DEA registration. (ada.org)
. This course will meet the one-time federal requirement.
A few points of clarification on the new DEA required 8 hour course.
1. The LDA DEA course will not only count towards your new DEA requirements but you can also use it towards your in-person, clinical hours to renew your LA State Board of Dentistry license.
2. If you took opioid courses in the past, they may count towards your 8 hours! You must have your proof of C.E. and check that the course was given by an ADA CERP recognized organization. If it was not, your previously taken course will not count for the new DEA requirement.
Speaker: Professor Karen Baker
Professor Karen Baker has been on the Dental College faculty at the University of Iowa for over 40 years and occupies a unique role in dental practice and education. She is a clinical pharmacist with a Master’s degree in clinical pharmacology and therapeutics and is focused on patient-specific dental drug therapy. She has given well over 1000 invited programs nationally and internationally and holds memberships in many dental and clinical pharmacology and therapeutics organizations. Her dental education-based pharmacy and drug therapy consultation center is the only one in the United States. She has authored many articles and abstracts and lectures extensively in pre-doctoral and graduate courses at the University of Iowa.
Title: DEA MATE Act Training: Dental Implications of Substance Use Disorders
Substance Use Disorders (SUDs) are unfortunately both common and destructive in our society. We will discuss new developments in the neurophysiology and treatment of common SUDs. Recreational marijuana is currently legal in 21 states and initiatives are currently being promoted in many more states. We will review the pharmacology of cannabis products and discuss oral effects and dental treatment ramifications for patients who frequently use cannabinoids with special emphasis on risks of high potency THC among adolescents.
Both unethical promotion and rampant over prescribing of opioids have contributed to the current public health emergency we face in the United States. We will discuss the unique risks associated with opioid use and outline strategies for opioid-sparing analgesia in dental practice. We will identify effective pain relief alternatives based on individual patient characteristics. Finally, we will discuss identification and management of addiction and impairment in the dental professional. Extensive and very current handouts will maximize the chairside value of this timely and practical information.
After attending this course and reviewing the handouts, the participant should be able to:
- Discuss the neurophysiology and neurotransmitter basis for SUDs,
- Describe the mental health disorders that predispose to SUDs,
- List the dental pain management and anesthesia implications of chronic cannabis use,
- Identify the signs and symptoms & treatment alternatives for alcoholism and other SUDs,
- Review the causes for and consequences of the current opioid epidemic in the U.S.,
- Explain the relative pain relief effectiveness of non-opioid and opioid agents in acute pain, &
- Discuss the benefits and risks of specific pain control regimens for effective dental analgesia.
For more information about the MATE Act, click here.
|Early Registration Pricing
(Available until 12/28)
(Available from 12/29-1/10)
New Orleans Dental Association is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or the Commission for Continuing Education Provider Recognition at CCEPR.ADA.org. New Orleans Dental Association designates this activity for 8 credit hours continuing education credit. This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between New Orleans Dental Association and Louisiana Dental Association.
Premier Events Partners